T1D Exchange Outcomes Research Spotlight: Severe Hypoglycemia and Impaired Awareness of Hypoglycemia in Registry Participants
Outcomes Research with our Registry Our mission at T1D Exchange is to improve the lives of people living with type…
Insulin-Producing Therapy Shows Continued Promise for Type 1 Diabetes in Human Trials
In recent years, research has made impressive strides in developing potentially life-changing treatments for people with type 1 diabetes (T1D)….
The Journey to a Potential Islet Cell Replacement Therapy for Type 1 Diabetes
When Doug Melton, Ph.D., began his mission to develop an insulin-producing beta cell from a stem cell, he predicted it…
Type 1 Diabetes Stem Cell Therapy Gets Greenlight for Human Trials
On March 9, 2023, Vertex Pharmaceuticals received FDA clearance to begin human trials with a new stem cell therapy, VX-264….
